Arbutus Biopharma Corporation logo
Arbutus Biopharma Corporation ABUS
$ 3.22 0.31%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Arbutus Biopharma Corporation Balance Sheet 2011-2024 | ABUS

Annual Balance Sheet Arbutus Biopharma Corporation

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-107 M -49.3 M -28.4 M -36.9 M -42.3 M -11.4 M -167 M -72.2 M -68.7 M -47 M -9 M

Long Term Debt

- 1.82 M 2.23 M 2.59 M - - 12 M 12 M - - - - -

Long Term Debt Current

425 K 372 K 383 K 390 K 340 K - - - - - - - -

Total Non Current Liabilities

- - - 25.6 M 25 M 16.4 M 40.1 M 62.3 M 154 M 9.94 M - 723 K 1.66 M

Total Current Liabilities

22.5 M 32.9 M 11.2 M 9.54 M 7.83 M 11.2 M 14.6 M 10.6 M 10.6 M 20.2 M - - -

Total Liabilities

38.4 M 58.6 M 35 M 35.1 M 32.8 M 27.7 M 54.7 M 72.9 M 165 M 30.1 M 12.5 M 11.7 M 8.5 M

Deferred Revenue

11.8 M 16.5 M - - - - 2.74 M 15 K 868 K 5.78 M 3.46 M 3.14 M 2.75 M

Retained Earnings

-1.28 B -1.2 B -1.13 B -1.05 B -970 M -805 M -738 M -651 M -267 M -206 M -167 M -230 M -254 M

Total Assets

144 M 195 M 204 M 137 M 106 M 228 M 237 M 276 M 712 M 118 M 71.7 M 52.6 M 13.7 M

Cash and Cash Equivalents

26.3 M 30.8 M 109 M 52.3 M 31.8 M 36.9 M 54.3 M 23.4 M 167 M 72.2 M 68.7 M 47 M 9.03 M

Book Value

106 M 137 M 169 M 102 M 72.7 M 200 M 182 M 203 M 548 M 88 M 59.2 M 40.9 M 5.21 M

Total Shareholders Equity

106 M 137 M 169 M 102 M 72.7 M 200 M 182 M 203 M 548 M 88 M 59.2 M 40.9 M 5.23 M

All numbers in USD currency

Quarterly Balance Sheet Arbutus Biopharma Corporation

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - 1.34 M - - - 1.82 M - - - 2.23 M 2.36 M 2.48 M 2.48 M 2.59 M 2.59 M 2.59 M 2.59 M 3.02 M 3.02 M 3.02 M 3.02 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

33.6 M 37.6 M 35.7 M 38.4 M 39.3 M 42.1 M 47.3 M 58.6 M 58.3 M - 71 M 35 M 35.5 M 34.5 M 32.1 M 35.1 M 35.1 M 35.1 M 35.1 M 32.8 M 32.8 M 32.8 M 32.8 M 27.7 M 27.7 M 27.7 M 27.7 M 54.7 M 54.7 M 54.7 M 54.7 M 72.9 M 72.9 M 72.9 M 72.9 M 165 M 165 M 165 M 165 M 30.1 M 30.1 M 30.1 M 30.1 M 12.5 M 12.5 M 12.5 M 12.5 M - - - - - - - -

Deferred Revenue

10.9 M 11 M 11.5 M 11.8 M 12.1 M 15.3 M 15.1 M 16.5 M 14.9 M - 23.3 M - - - - - - - - - - - - - 649 K 974 K 1.72 M 2.74 M 15 K 2.62 M 2.62 M 15 K 15 K 15 K 15 K 868 K 868 K 868 K 868 K 5.78 M 5.78 M 5.78 M 5.78 M 3.46 M 3.46 M 3.46 M 3.46 M - - - - - - - -

Retained Earnings

-1.33 B -1.31 B -1.29 B -1.28 B -1.26 B -1.24 B -1.22 B -1.2 B -1.18 B - -1.15 B -1.13 B -1.11 B -1.09 B -1.07 B -1.05 B -1.05 B -1.05 B -1.05 B -970 M -970 M -970 M -970 M -805 M -805 M -805 M -805 M -738 M -738 M -738 M -738 M -653 M -651 M -651 M -651 M -267 M -267 M -267 M -267 M -206 M -206 M -206 M -206 M -167 M -167 M -167 M -167 M - - - - - - - -

Total Assets

140 M 160 M 150 M 144 M 159 M 177 M 191 M 195 M 204 M - 237 M 204 M 166 M 135 M 146 M 137 M 137 M 137 M 137 M 106 M 106 M 106 M 106 M 228 M 228 M 228 M 228 M 237 M 237 M 237 M 237 M 276 M 276 M 276 M 276 M 712 M 712 M 712 M 712 M 118 M 118 M 118 M 118 M 71.7 M 71.7 M 71.7 M 71.7 M - - - - - - - -

Cash and Cash Equivalents

31.8 M 62.8 M 43.1 M 26.3 M 17.5 M 27.2 M 40.6 M 30.8 M 24 M 47.3 M 81.3 M 109 M 77.9 M 31 M 79.4 M 52.3 M 52.3 M 52.3 M 52.3 M 31.8 M 31.8 M 31.8 M 31.8 M 36.9 M 36.9 M 36.9 M 36.9 M 54.3 M 54.3 M 54.3 M 54.3 M 23.4 M 23.4 M 23.4 M 23.4 M 167 M 167 M 167 M 167 M 72.2 M 72.2 M 72.2 M 72.2 M 68.7 M 68.7 M 68.7 M 68.7 M 47 M - - - 9.03 M - - -

Book Value

107 M 122 M 115 M 106 M 119 M 135 M 144 M 137 M 146 M - 166 M 169 M 130 M 101 M 114 M 102 M 102 M 102 M 102 M 72.7 M 72.7 M 72.7 M 72.7 M 200 M 200 M 200 M 200 M 182 M 182 M 182 M 182 M 203 M 203 M 203 M 203 M 548 M 548 M 548 M 548 M 88 M 88 M 88 M 88 M 59.2 M 59.2 M 59.2 M 59.2 M - - - - - - - -

Total Shareholders Equity

107 M 122 M 115 M 106 M 119 M 135 M 144 M 137 M 146 M 153 M 166 M 169 M 130 M 101 M 114 M 102 M 102 M 102 M 102 M 72.7 M 72.7 M 72.7 M 72.7 M 200 M 200 M 200 M 200 M 182 M 182 M 182 M 182 M 203 M 203 M 203 M 203 M 548 M 548 M 548 M 548 M 88 M 88 M 88 M 88 M 59.2 M 59.2 M 59.2 M 59.2 M 40.9 M - - - 5.23 M - - -

All numbers in USD currency